Col1a1tm20(CAG-Myc,-luc2)Nki
Targeted Allele Detail
|
Symbol: |
Col1a1tm20(CAG-Myc,-luc2)Nki |
Name: |
collagen, type I, alpha 1; targeted mutation 20, The Netherlands Cancer Institute |
MGI ID: |
MGI:6324312 |
Synonyms: |
Col1a1invCAG-Myc-IRES-Luc |
Gene: |
Col1a1 Location: Chr11:94827050-94843868 bp, + strand Genetic Position: Chr11, 59.01 cM, cytoband D
|
Alliance: |
Col1a1tm20(CAG-Myc,-luc2)Nki page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:276500
|
Parent Cell Line: |
Other (see notes) (ES Cell)
|
Strain of Origin: |
Not Specified
|
|
Allele Type: |
|
Targeted (Conditional ready, Inserted expressed sequence, Reporter) |
Mutation: |
|
Insertion
|
|
|
Mutation details: RMCE introduced into the 3' UTR an FRT-flanked cassette containing an inverted lox71/lox66-flanked CAG promoter, full-length Myc sequence, IRES sequence and firefly luciferase reporter gene (fLuc2).
(J:276500)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Col1a1 Mutation: |
166 strains or lines available
|
|
|
Original: |
J:276500 Annunziato S, et al., Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer. Nat Commun. 2019 Jan 23;10(1):397 |
All: |
2 reference(s) |
|